Old Web
English
Sign In
Acemap
>
Paper
>
P08.04 Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
P08.04 Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
2021
Lyudmilla Bazhenova
Nicolas Girard
Anna Minchom
S-H.I. Ou
Shirish M. Gadgeel
José Manuel Trigo
Santiago Viteri
Anil Londhe
P. Mahadevia
Joshua Bauml
Keywords:
Wild type
immune checkpoint inhibitors
Medicine
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]